BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8514604)

  • 1. Clonal analysis of multiple point mutations in the N-ras gene in patients with acute myeloid leukemia.
    Kubo K; Naoe T; Kiyoi H; Fukutani H; Kato Y; Oguri T; Yamamori S; Akatsuka Y; Kodera Y; Ohno R
    Jpn J Cancer Res; 1993 Apr; 84(4):379-87. PubMed ID: 8514604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes.
    Chin YM; Bosco JJ; Koh CL
    Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of genetic material is more common than gain in acute myeloid leukemia with complex aberrant karyotype: a detailed analysis of 125 cases using conventional chromosome analysis and fluorescence in situ hybridization including 24-color FISH.
    Schoch C; Haferlach T; Bursch S; Gerstner D; Schnittger S; Dugas M; Kern W; Löffler H; Hiddemann W
    Genes Chromosomes Cancer; 2002 Sep; 35(1):20-9. PubMed ID: 12203786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High incidence of conservative RAS mutations in acute myeloid leukemia.
    Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP
    Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of point mutations in p53 gene is not increased in patients with acute myeloid leukaemia carrying an activating N-ras mutation.
    Bühler-Leclerc M; Gratwohl A; Senn HP
    Br J Haematol; 1993 Jul; 84(3):443-50. PubMed ID: 8217795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent rearrangements of retinoic acid receptor alpha gene and myl gene, and rare mutations of RAS and FMS genes in acute promyelocytic leukemia.
    Yamamoto K; Hirosawa S; Sakamaki H; Aoki N
    Am J Hematol; 1992 Aug; 40(4):252-8. PubMed ID: 1323928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia.
    Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA
    Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between MDR1 genetic polymorphism and prognosis in acute myeloid leukemia].
    Wang D; Ke XY; Wang J; Xu F; Hu YF
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1384-8. PubMed ID: 17785057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ras point mutations occur in acute myeloid leukemia with illegitimate T-cell receptor delta gene rearrangement.
    Schmidt CA; Przybylski G; Vogel D; Ludwig WD; Oettle H; Neubauer A; Siegert W
    Leukemia; 1994 Jan; 8(1):102-5. PubMed ID: 8289473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia.
    Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP
    Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
    Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
    Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of immunophenotype to cytogenetics and clinical features of adult acute myeloid leukemia].
    Wang XB; Zheng JE; Gu JX; Yao JX; Yang J; Liu J; Li XQ; He YL; Yu JM; Wei J; Liu ZP; Huang SA
    Ai Zheng; 2005 Jun; 24(6):667-71. PubMed ID: 15946475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
    Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
    Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis.
    Todd AV; Ireland CM; Radloff TJ; Kronenberg H; Iland HJ
    Am J Hematol; 1991 Nov; 38(3):207-13. PubMed ID: 1951319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implication of N-RAS gene mutations in Egyptian adult acute myeloid leukemia.
    Elghannam DM; Abousamra NK; Shahin DA; Goda EF; Azzam H; Azmy E; El-Din MS; El-Refaei MF
    Egypt J Immunol; 2009; 16(1):9-15. PubMed ID: 20726318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute myeloid leukemia: analysis of ras gene mutations and clonality defined by polymorphic X-linked loci.
    Bartram CR; Ludwig WD; Hiddemann W; Lyons J; Buschle M; Ritter J; Harbott J; Fröhlich A; Janssen JW
    Leukemia; 1989 Apr; 3(4):247-56. PubMed ID: 2564452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.